Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Research Samples
16 Results
1 - 16 of 16 total samples.
Advanced Data View:
1 - 16 of 16 total samples.
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test 1 Result | Test 1 Detail | Test 2 | Test 2 Result | Test 3 | Test 3 Result | Product Details | Price | Buy | Elastography Result | Comorbidities | Ultrasound Result | Smoking Status | Alcohol Consumption | HIV-I/II, Hepatitis B, Hepatitis C Test Results | CT / MRI results |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BF19871147 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 44 Y | M | White | <-70C | 15-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 2022 | Height | 172 cm | Weight | 81 kg | $400.00 | Diffuse liver changes, consistent with METAVIR F2 fibrosis 14-Oct-2025 | Diabetes mellitus type 1 2005 | Signs of moderate hepatic steatosis, pancreatic cyst. Right kidney cyst. | Never used | Never used | Negative | ||||
| BF19871148 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 63 Y | F | White | <-70C | 07-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 3-Oct-2025 | Height | 160 cm | Weight | 100 kg | $400.00 | Sonographic signs of chronic hepatitis, consistent with METAVIR F2 fibrosis, and hepatic steatosis 3-Oct-2025 | Diabetes mellitus type 2; Obesity class II; Chronic venous insufficiency, stage 2 2020; 2018; 2014 | Never used | Never used | Negative | |||||
| BF19871149 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 13.00 | $400.00 | 69 Y | M | White | <-70C | 09-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 9-Oct-2025 | Height | 170 cm | Weight | 88 kg | $400.00 | Ultrasound signs of chronic hepatitis, METAVIR F2 fibrosis, and severe hepatic steatosis 9-Oct-2025 | Ischemic heart disease; Hypertension; Heart failure; Diabetes mellitus type 2; Obesity class I 2008; 2010; 2012; 2014; 2008 | Never used | Never used | Negative | |||||
| BF19871167 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 58 Y | M | White | <-70C | 01-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 1-Oct-2025 | Height | 178 cm | Weight | 88 kg | $400.00 | Mean liver stiffness: 6.4 kPa (F1 by METAVIR) 1-Oct-2025 | Ischemic heart disease; Hypertension 2017; 2019 | Signs of hepatic steatosis and diffuse changes in the pancreatic structure | Current Cigarette Use (25/day, 35 years) | Never used | Negative | ||||
| BF19871170 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 61 Y | F | White | <-70C | 02-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 2-Oct-2025 | Height | 155 cm | Weight | 61 kg | $400.00 | Mean liver stiffness: 6.4 kPa (F1 by METAVIR) 2-Oct-2025 | Hypertension 2019 | Signs of steatohepatosis | Never used | Never used | Negative | ||||
| BF19871172 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 69 Y | F | White | <-70C | 01-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 1-Oct-2025 | Height | 159 cm | Weight | 67 kg | $400.00 | Mean liver stiffness: 6.6 kPa (F1 by METAVIR) 1-Oct-2025 | Hypertension; Heart failure 2007; 2010 | Findings of steatohepatitis and chronic calculous cholecystitis in remission. Cholelithiasis | Never used | Never used | Negative | ||||
| BF19871196 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 15.00 | $400.00 | 74 Y | F | White | <-70C | 16-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 10-Oct-2025 | Height | 169 cm | Weight | 90 kg | $400.00 | Mean liver stiffness: 6.2 kPa (F1 by METAVIR) 10-Oct-2025 | Ischemic heart disease; Hypertension 2002; 2006 | Never used | Never used | Negative | |||||
| BF19871228 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 54 Y | M | White | <-70C | 18-Feb-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 2012 | Height | 176 cm | Weight | 74 kg. | $500.00 | Oblique vertical size of the right lobe 178 mm, left lobe 76 mm. The structure is changed, fatty degeneration 70%. K3 is 297 dB/m. Steatosis S3. 27-Jan-25 | N/A | Never used | Never used | Negative | |||||
| BF19871231 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 73 Y | F | White | <-70C | 04-Mar-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 3-Mar-25 | Height | 162 cm | Weight | 76 kg. | $500.00 | The average value of the elasticity of the parenchyma of the liver is 5.6 kPa. On the METAVIR scale - F0. Moderate steatosis. 3-Mar-25 | N/A | Never used | Never used | Negative | The liver is moderately enlarged, the contours are even, the boundaries are clear. The structure of the parenchyma is heterogeneous. Moderate steatosis. | ||||
| BF19871246 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 62 Y | F | White | <-70C | 21-Feb-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 2023 | Height | 172 cm | Weight | 87 kg. | $500.00 | The average value of the elasticity of the parenchyma of the liver is 5.5 kPa. On the METAVIR scale - F0. 21-Feb-25 | N/A | Never used | Never used | Negative | |||||
| BF19871251 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 34 Y | M | White | <-70C | 12-Feb-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 2022 | Height | 178 cm | Weight | 76 kg. | $500.00 | Oblique vertical size of the right lobe 162 mm, left lobe 70 mm. The structure is changed, fatty degeneration 35%. K3 is 258 dB/m. Steatosis S2. 22-Jan-25 | N/A | Never used | Never used | Negative | |||||
| BF19871280 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 53 Y | F | White | <-70C | 18-Feb-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 2022 | Height | 167 cm | Weight | 72 kg. | $500.00 | The average value of the elasticity of the parenchyma of the liver is 6.2 kPa. On the METAVIR scale - F1. 18-Feb-25 | N/A | Never used | Never used | Negative | |||||
| BF19871283 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 40 Y | M | White | <-70C | 18-Feb-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 2018 | Height | 178 cm | Weight | 75 kg. | $500.00 | Oblique vertical size of the right lobe 168 mm, left lobe 80 mm. The structure is changed, fatty degeneration 40%. K3 is 258 dB/m. Steatosis S2. 30-Jan-25 | N/A | Never used | Never used | Negative | |||||
| BF19871288 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 1.00 | $500.00 | 48 Y | M | White | <-70C | 17-Apr-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 16-Apr-25 | Height | 187 cm | Weight | 75 kg. | $500.00 | Elastometry results: Young's median 6.5 kPa, 1.52 m/s (IQR <30%) corresponding to F1-F2 for METAVIR scale. Moderate steatosis. 16-Apr-25 | N/A | Never used | Never used | Negative | The liver is slightly enlarged. The oblique vertical dimension of the right lobe of the liver is 162 mm, the thickness of the left lobe is 78 mm, contours are smooth, the boundaries are clear. The structure is heterogeneous due to perportal fibrosis | ||||
| BF19871335 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 14.00 | $400.00 | 55 Y | F | White | <-70C | 29-Oct-25 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 2022 | Height | 165 cm | Weight | 88 kg | $400.00 | Mean liver stiffness: 4.84 kPa (F0-F1 by METAVIR) 20-Oct-2025 | Obesity class I 2014 | Never used | Current Use (1/day, 20 years) | Negative | |||||
| BF19871453 | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | Ukraine | Serum | 1.00 | 12.00 | $400.00 | 49 Y | M | White | <-70C | 17-Feb-26 | Diagnosis | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) | 2-Jan-26 | Height | 172 cm | Weight | 94 kg | $400.00 | Mean liver stiffness: 8.2 kPa (F3 by METAVIR) 17-Feb-26 | Hypertension; Obesity class I 2020; 2018 | Never used | Never used | Negative |